Natasha S.Gold

Associate

(T) + 61.3.9101.6827

Natasha Gold handles intellectual property disputes in the High Court of Australia, Federal Court of Australia, and Australian Patent Office. In particular she acts in high-profile, multijurisdictional, and complex patent infringement and revocation litigation. Her patent experience includes matters relating to small molecules, antibodies, CRISPR gene editing technology, devices, and veterinary products.

Natasha advises clients across a variety of industries, particularly on patents, pharmaceutical and health care regulation, copyright, trademarks, confidential information and trade secrets, and privacy and consumer protection.

Prior to joining Jones Day, Natasha was the Associate to Justice David Yates at the Federal Court of Australia, where she gained extensive experience in intellectual property, corporate, and appellate matters.

Experience

  • Sanofi challenges Amgen's patent applications for anti-PCSK9 antibodies before Australian Patent OfficeJones Day is acting in an opposition proceeding for Sanofi and Regeneron in relation to their challenge to a portfolio of applications held by Amgen Inc. that claim anti-PCSK9 antibodies and their use in the treatment of hypercholesterolemia.
  • ToolGen defends revolutionary CRISPR technology patentJones Day is acting for ToolGen, Inc. in relation to a challenge to its patent rights concerning CRISPR, a technology that has revolutionized the field of molecular biology including gene editing in the medical, biotechnology, and agricultural and farming industries.
  • Idenix asserts patent infringement against Gilead in Australia related to Sovaldi® and Harvoni®Jones Day represents Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co., Inc.) in patent litigation against Gilead in the Federal Court of Australia over sofosbuvir, the active ingredient in Sovaldi® and Harvoni®, Gilead's blockbuster drugs for treating Hepatitis C.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.